Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04912895 · ClinicalTrials.gov registry record · NA
Detection of SARS-CoV-2 RNA in Coughed Droplets From Patients With COVID-19
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 69
- Enrollment target
NCT04912895 is a NA study that has completed, run by Emory University. The registered enrollment target is 69 participants.
The verdict
NCT04912895, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 69 participants
- Enrollment target
Study Summary
The purpose of this study is to learn how to better detect infection and understand how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes lung disease and is spread. The novel device called PneumoniaCheck is a safe way to collect material from the lung from coughs. Study participants will collect cough specimens over a 24 hour period.
Interventions
- DEVICE PneumoniaCheck
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2021-04-14 |
| Est. Completion | 2022-08-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04912895
The ClinicalTrials.gov registry entry for NCT04912895 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PneumoniaCheck is the first listed.
NCT04912895 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04912895 about?
NCT04912895 is a clinical study titled "Detection of SARS-CoV-2 RNA in Coughed Droplets From Patients With COVID-19". The purpose of this study is to learn how to better detect infection and understand how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes lung disease and is spread. The novel device called PneumoniaCheck is a safe way to collect material from the lung from coughs. Study participan...
What is the current status of trial NCT04912895?
This trial is currently completed. It is a NA study. The enrollment target is 69 participants. The study started on 2021-04-14. Estimated completion is 2022-08-05.
What interventions are being tested in trial NCT04912895?
The interventions under investigation include: PneumoniaCheck (DEVICE).
Who is sponsoring clinical trial NCT04912895?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.